Prevalence of factors influencing cancer risk in women with lupus: Social habits, reproductive issues, and obesity

Journal of Rheumatology

Volumn 29, Issue 12, 2002, Pages 2551-2554

  Bernatsky, Sasha ^a,b   Boivin, Jean François ^a,b   Joseph, Lawrence ^a,b   St Pierre, Yvan ^a,b   Moore, Andrew ^a,b   Rajan, Raghu ^a,b   Clarke, Ann ^a,b  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Cancer risk factors; Malignancy; Systemic lupus erythematosus

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BREAST CANCER; CANCER RISK; CIGARETTE SMOKING; COHORT ANALYSIS; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; FEMALE; GYNECOLOGIC CANCER; HUMAN; LUNG CANCER; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; OBESITY; ORAL CONTRACEPTION; PREVALENCE; PRIORITY JOURNAL; REPRODUCTION; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; ANAMNESIS; CANADA; LIFESTYLE; MIDDLE AGED; NEOPLASM;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; LIFE STYLE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; NEOPLASMS; OBESITY; QUEBEC; REPRODUCTIVE HISTORY; RISK FACTORS;

EID: 0036894859     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sweeney DM, Manzi S, Janosky J, et al. Risk of malignancy in women with SLE. J Rheumatol 1995;22:1478-2.
2. Ramsey-Goldman R, Clarke A. Double trouble: Are lupus and malignancy associated? Lupus 2001;10:388-91.
3. Cibere J, Sibley J, Haga M. Systemic lupus erythematosus and the risk of malignancy. Lupus 2001;10:394-400.
4. Pettersson T, Pukkala E, Teppo L, Friman C. Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis 1992;51:437-9.
5. Ramsey-Goldman R, Mattai SA, Schilling E, et al. Increased risk of malignancy in patients with systemic lupus erythematosus. J Invest Med 1998;46:217-22.
6. Sultan SM, Ioannou Y, Isenberg DA. Is there an association of malignancy with SLE? An analysis of 276 patients under long-term review. Rheumatology 2000;39:1147-52.
7. Abu-Shakra M, Gladman DD, Urowitz MB. Malignancy in systemic lupus erythematosus. Arthritis Rheum 1996;39:1050-4.
8. Nived O, Bengtsson A, Jonsen A, Sturfelt G, Olsson H. Malignancies during follow-up in an epidemiologically defined SLE inception cohort in southern Sweden. Lupus 2001;10:500-4.
9. Bernatsky S, Boivin J, Clarke A, Rajan R. Cancer risk in SLE: A meta-analysis [abstractl. Arthritis Rheum 2001;44 Suppl:S244.
10. Talal N. Autoimmunity and lymphoid malignancy in New Zealand black mouse. Prog Clin Immunol 1974;2:101-20.
11. Hamblin TJ, Oscier DG, Young BJ. Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol 1986;39:713-6.
12. Conley CL, Misiti J, Laster AJ. Genetic factors predisposing to chronic lymphocytic leukemia and to autoimmune disease. Medicine 1980;59:323-34.
13. Caligaris-Cappio F. B-chronic lymphocytic leukemia: A malignancy of anti-self B cells. Blood 1996;87:2615-20.
14. Kipps TJ, Carson CA. Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood 1993;81:2475-87.
15. Sthoeger ZM, Wakai M, Tse DB, et al. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med 1989;169:255-68.
16. Tan EM, Cohen AS, Fries JF, et al. The 1982 American College of Rheumatology revised criteria for the classification of SLE. Arthritis Rheum 1982;25:1271-7.
17. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
18. National Population Health Survey, 1996-97 [Computer File]: Public Use Microdata Files: Household Component. [[82M0009XCB1]. 1998. Ottawa, Statistics Canada, Health Statistics Division.
19. Guess HA, West R, Strand LM, et al. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. Clin Epidemiol 1988;41:35-45.
20. Byers T, Nestle M, McTiernan A, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2002;52:92-119.
21. Bernatsky S. Malignancy in Systemic Lupus Erythematosus [Dissertation]. Montreal: McGill University; 2001.
22. Dhar J, Kmak D, Bhan R, Pishorodi L, Ager J, Sokol R. Abnormal cervicovaginal cytology in women with lupus: A retrospective cohort study. Gynecol Oncol 2001;82:4-6.
23. Bateman H, Yazici Y, Leff L, Peterson M, Paget SA. Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: A preliminary study. Lupus 2000;9:542-4.
24. Yell JA, Burge SM. Warts and lupus erythematosus. Lupus 1993;2:21-3.
25. Ward MM, Studenski S. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 1992;152:2082-8.
26. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with SLE. Am J Med 1992;93:513-9.
27. Rahman P, Urowitz MB, Gladman DD, Bruce IN. Contribution of traditional risk factors to coronary artery disease in patients with SLE. J Rheumatol 1999;26:2363-8.
28. McAlindon T, Giannotta L, Taub N, D'Cruz D, Hughes G. Environmental factors predicting nephritis in systemic lupus erythematosus. Ann Rheum Dis 1993;52:720-4.
29. Bruce IN, Gladman DD, Urowitz MB. Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: A Quality improvement study. Clin Exp Rheumatol 1998;16:435-40.
30. Bernatsky S, Clarke A, Ramsey-Goldman R. Malignancy and systemic lupus erythematosus. Curr Rheumatol Rep 2002;4:351-8.